{{cart_num}}
My CartCAS：198904-31-3
Molecular Formula：C38H52N6O7
Molecular Weight：704.86
Storage：Powder:-20℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：Solid
Qty：
Size：
| CAS | 198904-31-3 |
| Name | Atazanavir |
| Molecular Formula | C38H52N6O7 |
| Molecular Weight | 704.86 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | Solid |
| Storage | Powder:-20℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 812-543-8 |
| MDL | MFCD08435966 |
| SMILES | CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC |
| Target Point | HIV |
| Passage | Anti-infection |
| Background | Atazanavir is a highly selective HIV-1 protease inhibitor. |
| Biological Activity | 是一种氮杂肽及HIV-蛋白酶抑制剂，常与其他抗HIV药物结合，用于治疗HIV感染以及获得性免疫缺乏综合征。Atazanavir 是 cytochrome P450 isozyme 3A (CYP3A4) 的底物和抑制剂，也是 P-glycoprotein 的抑制剂和诱导剂。[1-3] |
| Data Literature Source | [1] Piliero PJ，et al. Expert Opin Investig Drugs. 2002，11(9):1295-301. [2] Robillard KR，et al. Antimicrob Agents Chemother. 2014，58(3):1713-22. [3] Pyrko P，et al. Cancer Res. 2007，67(22):10920-8. |
| Unit | Bottle |
| Specification | 10mg 20mg 50mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
